Abstract
Using gas chromatography–mass spectrometer for studying and evaluating the intestinal microflora in humans with chronic gastroduodenitis compared to traditional methods of diagnosis and microbiological analysis can significantly extend the range of the defined microbiota and its possible changes at different phases of the disease, thus enabling successful correction of microflora and suggesting prospective targeted treatment, followed by evaluation of its effectiveness. The composition and quantity of microorganisms in the intestinal wall of 340 patients aged 12 to 18 years were analyzed using gas chromatography–mass spectrometer in the acute phase, in remission, and at the end of treatment.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
